<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00552448</url>
  </required_header>
  <id_info>
    <org_study_id>20076812</org_study_id>
    <nct_id>NCT00552448</nct_id>
  </id_info>
  <brief_title>Use of High Frequency Chest Compression in Pediatric Status Asthmaticus</brief_title>
  <official_title>Use of High Frequency Chest Compression (HFCC) in Pediatric Status Asthmaticus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Tech University Health Sciences Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas Tech University Health Sciences Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Asthma is a disease resulting in mucus hypersecretion and airways obstruction. This causes
      difficulty breathing. The High Frequency Chest Compressor (HFCC) is a device that has been
      shown to decrease respiratory complications in individuals with severe disability who are
      unable to clear airway secretions. There is a lack of studies using this device in children
      with asthma. The device has been shown in a study to be safe in children with asthma. The
      investigators propose that using this device in our pediatric patients hospitalized in the
      pediatric ICU with asthma will result in decreased pediatric ICU stay. The investigators will
      also look at asthma severity, total days of hospital stay and chest discomfort while on
      therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Asthma is the third largest cause of hospitalization in children under 15 years
      of age. It is a reversible obstructive lung disease caused by airway inflammation and
      constriction of the airway smooth muscle. Mucus producing glands of the airway become
      enlarged resulting in overproduction of mucus. All those factors result in airflow
      obstruction with airtrapping, ventilation/perfusion mismatch and hypoxia. Therapies such as
      beta-agonists (i.e. albuterol), anti-cholinergics (i.e. atrovent) and steroids are used for
      an acute asthma attack. Unfortunately, patients may develop status asthmaticus, in which a
      severe attack does not respond to nebulized bronchodilators, and require intensive care
      admission.

      HFCC is an FDA (1988 under Class II 510K) approved device/modality of chest physiotherapy
      which has been utilized in patients with mucus hypersecretion, atelectasis and pneumonia.
      There is a paucity of pediatric studies. A comparative retrospective/prospective data
      analysis on exacerbations and hospitalizations in medically fragile (profoundly disabled)
      children using outpatient HFCC showed that use of this therapy reduced days of
      hospitalization for pulmonary exacerbations. Long term use in quadriplegic children reduced
      pulmonary secretions, incidence of pneumonia, and number of hospitalizations. In the
      pediatric cystic fibrosis population, there was improvement of lung function during
      hospitalization and long term decrease in progression of lung disease. Furthermore, in
      patients with mild to moderate asthma, there was no decline in lung function with the use of
      beta agonist and HFCC versus beta agonist alone indicating good tolerance and safety.

      Because asthma patients have mucus hypersecretion and this modality has been shown to be
      effective in other patient populations with mucus hypersecretion, this modality can be used
      as a means of reducing pulmonary morbidity and thereby allowing the respiratory therapist to
      allocate his/her time more efficiently.

      Purpose:

      Assess efficacy of HFCC in PICU population ages 2 to 21 years of age with status asthmaticus

      Design: Prospective Randomized non blinded HFCC (administered 4 times a day for 20 minutes)
      with conventional PICU management of asthma exacerbation vs. conventional PICU management of
      asthma exacerbation alone. Child would not have any of the standard asthma medications
      changed or stopped because of this study.

      End Points of Interest:

      Primary

      1) PICU days - Average number of PICU days as researched is about 4.47 days. There may be
      factors such as non PICU floor availability and PICU rounds that may delay transfer from PICU
      to the non PICU floor. So the official discharge from PICU will be when the attending PICU
      physician announces or deems it acceptable for PICU discharge

      Secondary

        1. Length of hospitalization

        2. Pediatric Asthma Severity Score a validated asthma severity score in pediatric
           population: 1) observed level of respiratory distress 2) accessory muscle use 3)
           auscultation (degree of wheezing) 4) oxygen saturation 5) respiratory rate Scored
           observations 0, 1, or 2 and total the observation numbers for a Severity score

        3. Discomfort

      Patient inclusion 2 to 21 yo (VEST approved for over two yo) Admitted to PICU for status
      asthmaticus Negative urine pregnancy test prior to initiation of study in those with menses

      Patient Exclusion

      Absolute contraindication to VEST use:

        1. Unstable head or neck injury

        2. Active hemorrhage with hemodynamic instability

        3. Intracranial pressure &gt; 20 mmHg or those in whom intracranial pressures should be
           avoided (was a relative contraindication but after discussion moved to absolute)

      Presence of anomalies such as:

        1. Former premature infant with BPD

        2. Congenital bronchogenic or pulmonary anomaly (i.e. CF)

        3. Congenital heart disease
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Continuing review not submitted to IRB within 365 days.
  </why_stopped>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hours Spent in Pediatric ICU</measure>
    <time_frame>Number of hours from admission to discharge from PICU</time_frame>
    <description>Length of stay (hours) in Pediatric ICU.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Days of Hospital Admission</measure>
    <time_frame>Days</time_frame>
    <description>This is limited due to non collection by collaborating centers.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pediatric Asthma Severity Score (Modified Pulmonary Index Score)</measure>
    <time_frame>Discharge from PICU</time_frame>
    <description>Modified Pulmonary Index Score (MPIS): a validated asthma severity score in pediatric population (Carroll CL et al. A modified pulmonary index score with predictive value for pediatric asthma exacerbations, Ann Allergy Asthma Immunol 2005) Consists of: 1) oxygen saturation on room air 2) accessory muscle use 3) inspiratory to expiratory ratio 4) degree of wheezing 5) heart rate 6) respiratory rate Scored observations 0, 1, 2 or 3. Total score range 0 - 18. Mild exacerbation total less than 6, moderate exacerbation 6 - 10, severe exacerbation higher than 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Chest Discomfort</measure>
    <time_frame>During PICU admission</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Pediatric, Asthma, Acute Exacerbation, Pediatric ICU</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of the HFCC device in addition to standard therapy for status asthmaticus. The use of HFCC will not affect the therapy received</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will not use the VEST or HFCC. They will just have standard therapy for status asthmaticus. The standard therapy will not be affected if they are in this group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High Frequency Chest Compression VEST</intervention_name>
    <description>every 6 hours for 20 minutes</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  2 to 21 yo (VEST approved for over two yo) Admitted to PICU for status asthmaticus
             Negative urine pregnancy test prior to initiation of study in those with menses

        Exclusion Criteria:

          -  Absolute contraindication to VEST use:

               1. Unstable head or neck injury

               2. Active hemorrhage with hemodynamic instability

               3. Intracranial pressure &gt; 20 mmHg or those in whom intracranial pressures should be
                  avoided (was a relative contraindication but after discussion moved to absolute)

        Presence of anomalies such as:

          1. Former premature infant with BPD

          2. Congenital bronchogenic or pulmonary anomaly (i.e. CF)

          3. Congenital heart disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adaobi C Kanu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Tech University Health Sciences Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stony Brook University Medical Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spartanburg Regional Medical Center</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Tech University Health Sciences Center</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79430</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 1, 2007</study_first_submitted>
  <study_first_submitted_qc>November 1, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2007</study_first_posted>
  <results_first_submitted>July 7, 2016</results_first_submitted>
  <results_first_submitted_qc>September 12, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 14, 2016</results_first_posted>
  <last_update_submitted>September 12, 2016</last_update_submitted>
  <last_update_submitted_qc>September 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pediatric, asthma, pediatric ICU</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Status Asthmaticus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Pediatric Status Asthmatics Patients on HFCC Device</title>
          <description>Use of the HFCC device in addition to standard therapy for status asthmaticus. The use of HFCC will not affect the therapy received
High Frequency Chest Compression VEST: every 6 hours for 20 minutes</description>
        </group>
        <group group_id="P2">
          <title>Pediatric Status Asthmaticus Patients Not Using HFCC</title>
          <description>This group will not use the VEST or HFCC. They will just have standard therapy for status asthmaticus. The standard therapy will not be affected if they are in this group.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Pediatric Status Asthmatics Patients on HFCC Device</title>
          <description>Use of the HFCC device in addition to standard therapy for status asthmaticus. The use of HFCC will not affect the therapy received
High Frequency Chest Compression VEST: every 6 hours for 20 minutes</description>
        </group>
        <group group_id="B2">
          <title>Pediatric Status Asthmaticus Patients Not Using HFCC</title>
          <description>This group will not use the VEST or HFCC. They will just have standard therapy for status asthmaticus. The standard therapy will not be affected if they are in this group.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="36"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.95" spread="3.53"/>
                    <measurement group_id="B2" value="6.69" spread="3.93"/>
                    <measurement group_id="B3" value="6.28" spread="3.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Two or more Ethnicity/Races</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ethnicity/Race Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior Hospitalizations</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Home asthma medication</title>
          <description>Please note that because one subject may be on multiple classes of medication so the numbers will not add up</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bronchodilator alone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inhaled steroid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inhaled steroid-long acting bronchodilator</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>leukotriene receptor antagonist</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antihistamine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systemic steroid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Modified Pulmonary Index Score (Initial)</title>
          <description>Modified Pulmonary Index Score (MPIS): a validated asthma severity score in pediatric population (Carroll CL et al. A modified pulmonary index score with predictive value for pediatric asthma exacerbations, Ann Allergy Asthma Immunol 2005) Consists of: 1) oxygen saturation on room air 2) accessory muscle use 3) inspiratory to expiratory ratio 4) degree of wheezing 5) heart rate 6) respiratory rate. Scored observations 0, 1, 2 or 3. Total score range 0-18.
Mild exacerbation total less than 6, moderate exacerbation 6 – 10, severe exacerbation higher than 10</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.76" spread="2.91"/>
                    <measurement group_id="B2" value="6.42" spread="2.91"/>
                    <measurement group_id="B3" value="6.03" spread="2.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Hours Spent in Pediatric ICU</title>
        <description>Length of stay (hours) in Pediatric ICU.</description>
        <time_frame>Number of hours from admission to discharge from PICU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pediatric Status Asthmatics Patients on HFCC Device</title>
            <description>Use of the HFCC device in addition to standard therapy for status asthmaticus. The use of HFCC will not affect the therapy received
High Frequency Chest Compression VEST: every 6 hours for 20 minutes</description>
          </group>
          <group group_id="O2">
            <title>Pediatric Status Asthmaticus Patients Not Using HFCC</title>
            <description>This group will not use the VEST or HFCC. They will just have standard therapy for status asthmaticus. The standard therapy will not be affected if they are in this group.</description>
          </group>
        </group_list>
        <measure>
          <title>Hours Spent in Pediatric ICU</title>
          <description>Length of stay (hours) in Pediatric ICU.</description>
          <units>Hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.71" spread="8.33"/>
                    <measurement group_id="O2" value="23.76" spread="12.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Days of Hospital Admission</title>
        <description>This is limited due to non collection by collaborating centers.</description>
        <time_frame>Days</time_frame>
        <population>Data not collected</population>
        <group_list>
          <group group_id="O1">
            <title>Pediatric Status Asthmatics Patients on HFCC Device</title>
            <description>Use of the HFCC device in addition to standard therapy for status asthmaticus. The use of HFCC will not affect the therapy received
High Frequency Chest Compression VEST: every 6 hours for 20 minutes</description>
          </group>
          <group group_id="O2">
            <title>Pediatric Status Asthmaticus Patients Not Using HFCC</title>
            <description>This group will not use the VEST or HFCC. They will just have standard therapy for status asthmaticus. The standard therapy will not be affected if they are in this group.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Days of Hospital Admission</title>
          <description>This is limited due to non collection by collaborating centers.</description>
          <population>Data not collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pediatric Asthma Severity Score (Modified Pulmonary Index Score)</title>
        <description>Modified Pulmonary Index Score (MPIS): a validated asthma severity score in pediatric population (Carroll CL et al. A modified pulmonary index score with predictive value for pediatric asthma exacerbations, Ann Allergy Asthma Immunol 2005) Consists of: 1) oxygen saturation on room air 2) accessory muscle use 3) inspiratory to expiratory ratio 4) degree of wheezing 5) heart rate 6) respiratory rate Scored observations 0, 1, 2 or 3. Total score range 0 - 18. Mild exacerbation total less than 6, moderate exacerbation 6 – 10, severe exacerbation higher than 10</description>
        <time_frame>Discharge from PICU</time_frame>
        <population>Participants with available data</population>
        <group_list>
          <group group_id="O1">
            <title>Pediatric Status Asthmatics Patients on HFCC Device</title>
            <description>Use of the HFCC device in addition to standard therapy for status asthmaticus. The use of HFCC will not affect the therapy received
High Frequency Chest Compression VEST: every 6 hours for 20 minutes</description>
          </group>
          <group group_id="O2">
            <title>Pediatric Status Asthmaticus Patients Not Using HFCC</title>
            <description>This group will not use the VEST or HFCC. They will just have standard therapy for status asthmaticus. The standard therapy will not be affected if they are in this group.</description>
          </group>
        </group_list>
        <measure>
          <title>Pediatric Asthma Severity Score (Modified Pulmonary Index Score)</title>
          <description>Modified Pulmonary Index Score (MPIS): a validated asthma severity score in pediatric population (Carroll CL et al. A modified pulmonary index score with predictive value for pediatric asthma exacerbations, Ann Allergy Asthma Immunol 2005) Consists of: 1) oxygen saturation on room air 2) accessory muscle use 3) inspiratory to expiratory ratio 4) degree of wheezing 5) heart rate 6) respiratory rate Scored observations 0, 1, 2 or 3. Total score range 0 - 18. Mild exacerbation total less than 6, moderate exacerbation 6 – 10, severe exacerbation higher than 10</description>
          <population>Participants with available data</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.88" lower_limit="0" upper_limit="5"/>
                    <measurement group_id="O2" value="1.9" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Chest Discomfort</title>
        <time_frame>During PICU admission</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pediatric Status Asthmatics Patients on HFCC Device</title>
            <description>Use of the HFCC device in addition to standard therapy for status asthmaticus. The use of HFCC will not affect the therapy received
High Frequency Chest Compression VEST: every 6 hours for 20 minutes</description>
          </group>
          <group group_id="O2">
            <title>Pediatric Status Asthmaticus Patients Not Using HFCC</title>
            <description>This group will not use the VEST or HFCC. They will just have standard therapy for status asthmaticus. The standard therapy will not be affected if they are in this group.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Chest Discomfort</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Pediatric Status Asthmatics Patients on HFCC Device</title>
          <description>Use of the HFCC device in addition to standard therapy for status asthmaticus. The use of HFCC will not affect the therapy received
High Frequency Chest Compression VEST: every 6 hours for 20 minutes</description>
        </group>
        <group group_id="E2">
          <title>Pediatric Status Asthmaticus Patients Not Using HFCC</title>
          <description>This group will not use the VEST or HFCC. They will just have standard therapy for status asthmaticus. The standard therapy will not be affected if they are in this group.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chest discomfort (anticipated)</sub_title>
                <description>Chest discomfort was the only anticipated adverse event - there were no unanticipated adverse events</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Adaobi Kanu</name_or_title>
      <organization>TexasTech</organization>
      <phone>806 743 7336</phone>
      <email>adaobi.kanu@ttuhsc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

